Prognostic Value of Serial Postoperative Circulating Tumor DNA Assessment During Long-Term Follow-Up in Patients with Breast Cancer

Prognostic Value of Serial Postoperative Circulating Tumor DNA Assessment During Long-Term Follow-Up in Patients with Breast Cancer

Medicine, Medical Laboratory Science, Oncology, Life Sciences, Immunology,
Breast Cancer   Circulating Tumor DNA   Long-Term Follow-Up   Prognosis   Personalized Medicine  

Scientific Research Report Background Introduction Breast cancer is the most commonly diagnosed cancer worldwide among both men and women, and it is the leading cause of cancer-related deaths in women. The standard treatment for early-stage breast cancer usually involves surgery and (neo)adjuvant chemotherapy and/or endocrine therapy, aiming to eli...

Clinical Validation of AI-Powered PD-L1 Tumor Proportion Score Interpretation for Predicting Immune Checkpoint Inhibitor Response in NSCLC

Information Science, Artificial Intelligence, Medicine, Medical Laboratory Science, Oncology,
Artificial Intelligence   PD-L1   Tumor Proportion Score   Non-Small Cell Lung Cancer   Immune Checkpoint Inhibitors   Clinical Validation  

Clinical Validation of AI-based Interpretation of PD-L1 Tumor Proportion Score in Predicting Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer In the field of tumor treatment and diagnosis, the assessment of PD-L1 (Programmed Death-Ligand 1) Tumor Proportion Score (TPS) is a critical task, especially in predicting the response ...

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients with Newly Diagnosed Prostate Cancer

Medicine, Urology, Oncology,
Prostate Cancer   Cell-Cycle Risk Score   Radiation Therapy   Androgen-Deprivation Therapy   10-Year Metastasis Risk   Individualized Genomic Testing  

Using Cell Cycle Risk Score to Predict the Benefit of Radiotherapy Combined with ADT in Newly Diagnosed Prostate Cancer Patients Background Prostate cancer is one of the most common cancers among men globally. In terms of treatment, localized prostate cancer is often treated primarily with radiotherapy (RT). However, the efficacy of RT alone is oft...

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients with Advanced Prostate Cancer from Latin America: Challenges and Future Approaches

Medicine, Basic Medical Sciences, Geriatrics, Urology, Oncology, Life Sciences, Genetics,
homologous recombination repair   gene mutation   prostate cancer   Latin America   prospective study  

Academic Report for the Paper Titled “Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients with Advanced Prostate Cancer from Latin America: Challenges and Future Approaches” Background Prostate cancer is one of the most common cancers among men in Latin America and the Caribbean (LAC). According to the 2020 Glo...

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients

Medicine, Basic Medical Sciences, Hematology, Oncology,
Multiple Myeloma   Survival Prediction   Quantitative Model   Molecular Prognostic Factors   Continuous Risk Assessment  

Precision Medicine | Quantitative Comprehensive Survival Prediction for Patients with Multiple Myeloma: Based on Bortezomib Induction Therapy, High-Dose Treatment, and Autologous Stem Cell Transplantation Introduction Multiple myeloma is a malignant hematological disease characterized by the accumulation of clonal plasma cells within the bone marro...

Clonal Hematopoiesis in Patients with Neuroendocrine Tumor Treated with Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study

Clonal Hematopoiesis in Patients with Neuroendocrine Tumor Treated with Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study

Medicine, Endocrinology, Hematology, Oncology,
clonal hematopoiesis   neuroendocrine tumor   thrombocytopenia   lutetium-177   radionuclide therapy   myeloid neoplasm   genetic mutations  

Clonal Hematopoiesis and Risk of Thrombocytopenia in Neuroendocrine Tumor Patients Undergoing 177Lu Therapy: A Prospective Study Background and Research Motivation The incidence of Neuroendocrine Tumors (NETs) has gradually increased in recent years. Prognosis depends on various factors such as the location of the primary tumor, disease grading, st...